Stay updated on Pembrolizumab & Cetuximab in HNSCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page.

Latest updates to the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page
- Check4 days agoChange DetectedThe study page now displays Revision: v3.6.5, replacing the previous v3.6.4. This indicates a minor update to the page content or formatting.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating a minor update to the page template or backend. The change does not modify study details, eligibility criteria, endpoints, or results.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page's revision tag now shows v3.6.3, replacing v3.6.2. This indicates a minor update to the page’s revision metadata rather than a substantive change to the study content.SummaryDifference0.0%

- Check47 days agoChange DetectedA new revision label v3.6.2 was added to the revision history, and the older label v3.6.0 was removed.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded new sections and guidance (No longer looking for participants; How to Read a Study Record; Common Questions; How to Join a Study) and a page revision label (Revision: v3.6.0). Removed the older 'Intervention / Treatment' header and the previous Revision: v3.5.5.SummaryDifference0.4%

- Check68 days agoChange DetectedThe revision label on the page changed from v3.5.4 to v3.5.5. This reflects a metadata update indicating a new version of the page rather than a content change.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab & Cetuximab in HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page.